$18.03
-0.38-2.06%
At close: -
$18.03
0.000.00%
After Hours: Mar 28, 4:34 PM EDT
Comments
Loading...
BrightSpring Health Analyst Ratings and Price Targets | NASDAQ:BTSG | Benzinga
BrightSpring Health Services Inc has a consensus price target of $19.42 based on the ratings of 14 analysts. The high is $30 issued by UBS on January 29, 2025. The low is $11.5 issued by Deutsche Bank on February 20, 2024. The 3 most-recent analyst ratings were released by UBS, Morgan Stanley, and CJS Securities on January 29, 2025, December 17, 2024, and December 12, 2024, respectively. With an average price target of $25.67 between UBS, Morgan Stanley, and CJS Securities, there's an implied 42.36% upside for BrightSpring Health Services Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Morgan Stanley
CJS Securities
B of A Securities
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for BrightSpring Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 01/29/2025 | Buy Now | 66.39% | UBS | A.J. Rice68% | $22 → $30 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 10.93% | Morgan Stanley | Erin Wright 66% | $19 → $20 | Maintains | Overweight | Get Alert |
| 12/12/2024 | Buy Now | 49.75% | CJS Securities | Larry Solow45% | → $27 | Initiates | → Market Outperform | Get Alert |
| 12/11/2024 | Buy Now | 16.47% | B of A Securities | Joanna Gajuk67% | $19 → $21 | Maintains | Buy | Get Alert |
| 11/27/2024 | Buy Now | 16.47% | Wells Fargo | Stephen Baxter55% | $17 → $21 | Maintains | Overweight | Get Alert |
| 11/04/2024 | Buy Now | 22.02% | UBS | A.J. Rice68% | $20 → $22 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | 10.93% | Mizuho | Ann Hynes86% | $17 → $20 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | 10.93% | UBS | A.J. Rice68% | $16 → $20 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | — | Initiates | → Sector Weight | Get Alert |
| 10/03/2024 | Buy Now | 10.93% | BTIG | David Larsen44% | $15 → $20 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | -0.17% | Guggenheim | — | $15 → $18 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | -0.17% | Goldman Sachs | Jamie Perse61% | $21 → $18 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | -16.81% | BTIG | David Larsen44% | → $15 | Initiates | → Buy | Get Alert |
| 05/06/2024 | Buy Now | -11.26% | Wells Fargo | Stephen Baxter55% | $15 → $16 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | -27.9% | HSBC | Sidharth Sahoo53% | → $13 | Initiates | → Buy | Get Alert |
| 03/04/2024 | Buy Now | 27.57% | Goldman Sachs | Jamie Perse61% | $26 → $23 | Maintains | Buy | Get Alert |
| 02/20/2024 | Buy Now | -36.22% | Deutsche Bank | Pito Chickering67% | → $11.5 | Initiates | → Hold | Get Alert |
| 02/20/2024 | Buy Now | -16.81% | Leerink Partners | Whit Mayo67% | → $15 | Initiates | → Outperform | Get Alert |
| 02/20/2024 | Buy Now | -22.35% | B of A Securities | Joanna Gajuk67% | → $14 | Initiates | → Buy | Get Alert |
| 02/20/2024 | Buy Now | -16.81% | UBS | A.J. Rice68% | → $15 | Initiates | → Buy | Get Alert |
| 02/20/2024 | Buy Now | -16.81% | Wells Fargo | Stephen Baxter55% | → $15 | Initiates | → Overweight | Get Alert |
| 02/20/2024 | Buy Now | -0.17% | Jefferies | Brian Tanquilut45% | → $18 | Initiates | → Buy | Get Alert |
| 02/20/2024 | Buy Now | -0.17% | Morgan Stanley | Erin Wright 66% | → $18 | Initiates | → Overweight | Get Alert |
| 02/20/2024 | Buy Now | 44.2% | Goldman Sachs | Jamie Perse61% | → $26 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for BrightSpring Health (BTSG) stock?
The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by UBS on January 29, 2025. The analyst firm set a price target for $30.00 expecting BTSG to rise to within 12 months (a possible 66.39% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BrightSpring Health (BTSG)?
The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by UBS, and BrightSpring Health maintained their buy rating.
When was the last upgrade for BrightSpring Health (BTSG)?
There is no last upgrade for BrightSpring Health
When was the last downgrade for BrightSpring Health (BTSG)?
There is no last downgrade for BrightSpring Health.
When is the next analyst rating going to be posted or updated for BrightSpring Health (BTSG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on January 29, 2025 so you should expect the next rating to be made available sometime around January 29, 2026.
Is the Analyst Rating BrightSpring Health (BTSG) correct?
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $22.00 to $30.00. The current price BrightSpring Health (BTSG) is trading at is $18.03, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.